ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Arsanis and X4 Pharmaceuticals Announce Merger
November 28, 2018Arsanis and privately-held X4 Pharmaceuticals have entered into a definitive merger agreement under which X4 Pharmaceuticals is expected to merge with a wholly-owned subsidiary ..... -
Arsanis Granted Key Patents for ASN100 Covering Cross-Neutralizing S. aureus Toxin Antibodies
March 15, 2018Arsanis, Inc. today announced that the United States Patent and Trademark Office ("USPTO") issued U.S. -
Arsanis and Adimab Enter Into License Agreement to Target Respiratory Syncytial Virus (RSV) With Mon
February 28, 2017Arsanis, Inc., a clinical-stage biopharmaceutical company developing targeted monoclonal antibodies for pre-emptive and post-infection treatment of serious infectious diseases,
Pharma Sources Insight January 2025
